Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

NCT03353597 is registered in ClinicalTrials.gov with Chandra Duggirala as lead sponsor.

NCT NCT03353597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03353597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects
Lead sponsor
Chandra Duggirala
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 15, 2018
Completion date
December 15, 2022
Enrollment
2,120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging